06.20.25
In this episode, Drs. Waring and Chu share clinical insights and real-world experience from the first year of using the Teneo 317 excimer laser for correcting myopia and myopic astigmatism. As the first excimer platform to receive FDA approval in over 15 years, the Teneo 317 introduces modern performance to U.S. practices with its compact design, fast ablation speed, and intuitive user interface. The conversation covers key findings from the FDA clinical trial and early post-market use, including exceptional visual acuity outcomes, improved night vision, and high levels of patient satisfaction.
Sponsored by Bausch + Lomb
©2025 Bausch + Lomb TEN.0014.USA.25
View full description +
Subscribe
08.18.25
Workforce Development and Surgical Mentorship in Global Ophthalmic CareKevin Barber, MD; Cynthia Matossian, MD; and Sara O’Connor, MD, MPH
08.13.25
Unconscious Bias in Medicine (Part 2): From Awareness to ActionNeda Shamie, MD; and Tanya Trinh, MBBS, FRANZCO, FWCRS
08.01.25
Use Your Dream Team to Execute Your Keratoconus StrategyBrandon D. Ayres, MD; Susan DeGroot, MBA; and Vivian Cole, BA
Sponsored by Glaukos
07.17.25
Highlights From AECOS Europe 2025Jorge L. Alió, MD, PhD, FEBOphth, FWCRS; Ashraf Armia, MD, MSc, FRSC (GLASG), FACS; Arthur B. Cummings, MB ChB, FCS(SA), MMed(Ophth), FRCS(Edin); José L. Güell, MD, PhD; Bojan Pajic, MD, PhD, FEBO; William J. Link, PhD; Andrea Russo, MD, PhD; Kuldev Singh, MD, MPH; Suphi Taneri, MD, FEBOS-CR; and Tanya Trinh, MBBS, FRANZCO, FWCRS
07.09.25
Refractive Innovation in Private PracticeNeda Shamie, MD; and George O. Waring IV, MD, FACS
Show More